Dantrolè

Pi Sala, Núria; Nogue Xarau, Santiago

dc.contributor	Departament de Salut
dc.contributor.author	Pi Sala, Núria
dc.contributor.author	Nogue Xarau, Santiago
dc.date.accessioned	2023-11-23T11:07:37Z
dc.date.available	2023-11-23T11:07:37Z
dc.date.issued	2023-06
dc.identifier.citation	Pi Sala N, Nogué Xarau S. Dantrolè. Butll Antídots Cat. 2023 juny-set;06(02):1-3.
dc.identifier.uri	https://hdl.handle.net/11351/10643
dc.language.iso	cat
dc.language.iso	spa
dc.publisher	Departament de Salut
dc.relation.ispartofseries	Butlletí d’antídots de Catalunya;06(02)
dc.rights	Attribution-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nd/4.0/
dc.source	Scientia
dc.subject	Anestèsics - Efectes secundaris
dc.subject	Antídots
dc.subject.mesh	Dantrolene
dc.subject.mesh	/therapeutic use
dc.subject.mesh	Malignant Hyperthermia
dc.subject.mesh	/drug therapy
dc.title	Dantrolè
dc.title.alternative	Dantroleno
dc.type	info:eu-repo/semantics/article
dc.subject.decs	dantroleno
dc.subject.decs	/uso terapéutico
dc.subject.decs	hipertermia maligna
dc.subject.decs	/farmacoterapia
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.authoraffiliation	Societat Catalana de Farmàcia Clínica, Barcelona, Spain
dc.rights.accessrights	info:eu-repo/semantics/openAccess